Terminated PHASE4 INTERVENTIONAL 2-arm NCT00617279

GORE PROPATEN Vascular Graft vs. Disadvantaged Autologous Vein Graft (PRODIGY)

Comparison of Primary Patency Between GORE PROPATEN Vascular Graft and Disadvantaged Autologous Vein Graft For Below-Knee Arterial Bypass (PRODIGY Study)

Sponsor: W.L.Gore & Associates

Conditions Peripheral Arterial Occlusive Disease

Interventions Disadvantaged Autologous Vein Graft GORE PROPATEN Vascular Graft

Updated 8 times since 2017 Last updated: Dec 8, 2011 Started: Dec 31, 2007 Primary completion: Feb 28, 2010 Completion: Feb 28, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Study terminated due to low enrollment

Other terminated trials from W.L.Gore & Associates

See all terminations from W.L.Gore & Associates

Other Peripheral Arterial Occlusive Disease trials with similar outcome

Browse all Peripheral Arterial Occlusive Disease trials

Listed as NCT00617279, this PHASE4 trial focuses on Peripheral Arterial Occlusive Disease and remains terminated or withdrawn. Sponsored by W.L.Gore & Associates, it has been updated 8 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Terminated PHASE4
Sep 2024 — Sep 2025 [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Dec 2021 — Jul 2024 [monthly]

Terminated PHASE4
Jan 2021 — Dec 2021 [monthly]

Terminated PHASE4

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Terminated PHASE4
Feb 2017 — Jun 2018 [monthly]

Terminated PHASE4
Jan 2017 — Feb 2017 [monthly]

Terminated PHASE4

First recorded

Dec 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

W.L.Gore & Associates

Data source: W.L.Gore & Associates

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Albany, United States , Atlanta, United States , Baltimore, United States , Baton Rouge, United States , Birmingham, United States , Boston, United States , Chicago, United States , Cleveland, United States , Greenville, United States , Houston, United States and 7 more locations